Ken Fisher Edwards Lifesciences Corp Transaction History

Fisher Asset Management, LLC

$247 Billion
Q4 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fisher Asset Management, LLC holds 9,775,276 shares of EW stock, worth $693 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

9,775,276

Previous 9,078,311 7.68%

Holding current value

$693 Million

Previous $599 Million 20.8%

% of portfolio

0.29%

Previous 0.25%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$64.54 - $75.92 $45 Million - $52.9 Million	696,965 Added 7.68%	9,775,276 $724 Million
Q3 2024 Nov 12, 2024	BUY	$59.7 - $93.78 $48.2 Million - $75.7 Million	806,705 Added 9.75%	9,078,311 $599 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $54.4 Million - $60.8 Million	644,728 Added 8.45%	8,271,606 $764 Million
Q1 2024 May 09, 2024	BUY	$72.54 - $95.56 $36.2 Million - $47.6 Million	498,599 Added 6.99%	7,626,878 $729 Million
Q4 2023 Mar 05, 2024	SELL	$61.71 - $77.76 $346,378 - $436,466	-5,613 Reduced 0.08%	7,128,279 $544 Million
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $11.1 Million - $14 Million	-180,575 Reduced 2.47%	7,133,892 $544 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $48.9 Million - $65.8 Million	-705,173 Reduced 8.79%	7,314,467 $507 Million
Q2 2023 Dec 12, 2023	BUY	$81.41 - $94.33 $57.3 Million - $66.3 Million	703,324 Added 9.62%	8,017,791 $756 Million
Q2 2023 Aug 08, 2023	BUY	$81.41 - $94.33 $16.5 Million - $19.1 Million	202,581 Added 2.59%	8,019,640 $756 Million
Q1 2023 Dec 12, 2023	BUY	$74.26 - $84.51 $37.5 Million - $42.7 Million	505,072 Added 6.91%	7,819,539 $647 Million
Q1 2023 May 01, 2023	BUY	$74.26 - $84.51 $10.7 Million - $12.2 Million	144,441 Added 1.88%	7,817,059 $647 Million
Q4 2022 Feb 03, 2023	BUY	$68.3 - $87.44 $9.14 Million - $11.7 Million	133,880 Added 1.78%	7,672,618 $572 Million
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $17.1 Million - $22.3 Million	208,057 Added 2.84%	7,538,738 $623 Million
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $19.7 Million - $29.2 Million	227,736 Added 3.21%	7,330,681 $697 Million
Q1 2022 May 05, 2022	BUY	$101.96 - $128.34 $32.7 Million - $41.2 Million	320,643 Added 4.73%	7,102,945 $836 Million
Q4 2021 Feb 02, 2022	BUY	$106.37 - $130.68 $38 Million - $46.7 Million	357,605 Added 5.57%	6,782,302 $879 Million
Q3 2021 Oct 26, 2021	BUY	$102.91 - $122.75 $27.5 Million - $32.8 Million	267,356 Added 4.34%	6,424,697 $727 Million
Q2 2021 Jul 27, 2021	BUY	$83.84 - $104.76 $28.1 Million - $35.1 Million	334,627 Added 5.75%	6,157,341 $638 Million
Q1 2021 Apr 27, 2021	BUY	$78.68 - $90.67 $19.2 Million - $22.1 Million	244,081 Added 4.38%	5,822,714 $487 Million
Q4 2020 Jan 29, 2021	BUY	$71.69 - $91.23 $27.7 Million - $35.2 Million	386,233 Added 7.44%	5,578,633 $509 Million
Q3 2020 Nov 10, 2020	BUY	$67.19 - $87.44 $13.8 Million - $17.9 Million	204,982 Added 4.11%	5,192,400 $414 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $209 Million - $280 Million	3,632,715 Added 268.16%	4,987,418 $345 Million
Q1 2020 Apr 28, 2020	BUY	$52.41 - $81.0 $70.6 Million - $109 Million	1,346,783 Added 17004.84%	1,354,703 $256 Million
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $96,508 - $110,493	-1,346 Reduced 14.53%	7,920 $1.85 Million
Q3 2019 Oct 29, 2019	BUY	$61.55 - $75.43 $131,778 - $161,495	2,141 Added 30.05%	9,266 $2.04 Million
Q2 2019 Jul 30, 2019	BUY	$55.74 - $64.41 $397,147 - $458,921	7,125 New	7,125 $1.32 Million

Others Institutions Holding EW

# of Institutions

1,383

Shares Held

453M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account